Shares of Alexion fell nearly 12 percent Monday after the pharmaceutical company said it missed its goal in a trial of the drug Solaris.
Shares of Alexion fell nearly 12 percent Monday after the pharmaceutical company said it missed its goal in a trial of the drug Solaris.